Voyageur Pharmaceuticals Ltd. (VYYRF)

Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	19	6	4	6	7	2
Market Cap Growth	0.13%	65.46%	-34.03%	-17.18%	225.80%	-40.61%
Enterprise Value	18	6	4	6	6	2
Last Close Price	0.11	0.00	0.03	0.07	0.08	0.04
PB Ratio	18.09	20.15	3.70	5.48	4.81	9.32
P/TBV Ratio	18.09	20.15	3.70	5.48	4.81	9.32
Debt / Equity Ratio	0.03	0.13	0.03	0.02	0.02	0.88
Net Debt / Equity Ratio	-0.63	-0.25	0.02	-0.01	-0.41	0.87
Net Debt / EBITDA Ratio	0.36	0.07	-0.03	0.01	0.40	-0.27
Net Debt / FCF Ratio	0.34	0.24	-0.03	0.01	0.37	-0.61
Quick Ratio	0.49	0.11	0.06	0.10	1.39	0.02
Current Ratio	0.58	0.17	0.13	0.27	1.43	0.03
Return on Equity (ROE)	-261.78%	-181.07%	-96.50%	-104.07%	-185.44%	-214.90%
Return on Assets (ROA)	-52.14%	-39.76%	-35.90%	-43.03%	-64.23%	-49.37%
Return on Capital Employed (ROCE)	-167.60%	-300.60%	-82.10%	-106.70%	-101.50%	-311.90%
Earnings Yield	-11.98%	-18.83%	-26.36%	-21.86%	-22.39%	-39.91%
FCF Yield	-10.37%	-5.17%	-21.97%	-24.94%	-22.77%	-15.21%
Buyback Yield / Dilution	-14.68%	-5.46%	-21.03%	-13.89%	-34.24%	-22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.